English  |  正體中文  |  简体中文  |  總筆數 :2828323  
造訪人次 :  32226112    線上人數 :  899
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"petrylak d p"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-7 / 7 (共1頁)
1 
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2022-09-15T01:09:02Z Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial Petrylak D.P.; de Wit R.; Chi K.N.; Drakaki A.; Sternberg C.N.; Nishiyama H.; Castellano D.; Hussain S.A.; Fl?chon A.; Bamias A.; Yu E.Y.; van der Heijden M.S.; Matsubara N.; Alekseev B.; Necchi A.; G?czi L.; Ou Y.-C.; Coskun H.S.; Su W.-P.; Bedke J.; Gakis G.; Percent I.J.; Lee J.-L.; Tucci M.; Semenov A.; Laestadius F.; Peer A.; Tortora G.; Safina S.; Garcia del Muro X.; Rodriguez-Vida A.; Cicin I.; Harputluoglu H.; Tagawa S.T.; Vaishampayan U.; Aragon-Ching J.B.; Hamid O.; Liepa A.M.; Wijayawardana S.; Russo F.; Walgren R.A.; Zimmermann A.H.; Hozak R.R.; Bell-McGuinn K.M.; Powles T.; Wong S.-L.S.; Tan T.H.; Hovey E.J.; Clay T.D.; Wan Ng S.S.; Rutten A.; Machiels J.-P.; Dumez H.; Cheng S.Y.-S.; Ferrario C.; Sengeloev L.; Jensen N.V.; Thibault C.; Laguerre B.; Joly F.; Culine S.; Becht C.; Niegisch G.; St?ckle M.; Grimm M.-O.; Schwentner C.A.; Schultze-Seemann W.; Kalofonos H.; Mavroudis D.; Papandreou C.; Karavasilis V.; R?v?sz J.; Rosenbaum E.; Leibowitz-Amit R.; Kejzman D.; Sarid D.; Scagliotti G.V.; Bracarda S.; Massari F.; Osawa T.; Miyajima N.; Shinohara N.; Fukuta F.; Ohyama C.; Obara W.; Yamashita S.; Tomita Y.; Kawai K.; Fukasawa S.; Oyama M.; Yonese J.; Nagata M.; Uemura M.; Nishimura K.; Kawakita M.; Tsunemori H.; Hashine K.; Inokuchi J.; Yokomizo A.; Nagamori S.; Lee H.J.; Park S.H.; Rha S.Y.; Kim Y.J.; Lee Y.-G.; Vazquez Cort?s L.; Lorena Urzua Flores C.; Blaisse R.J.B.; Erdkamp F.L.G.; Aarts M.J.B.; Wojcik-Tomaszewska J.; Tomczak P.; Sikora-Kupis B.; Schenker M.; Herzal A.A.; Udrea A.A.; Karlov P.; Fomkin R.; Gajate Borau P.; Grande E.; Delgado Mignorance J.I.; Su Y.-L.; Li J.-R.; Lin C.-L.; Chia-Chi Lin; Yeh S.-P.; Erman M.; Urun Y.; Golovko Y.; Bondarenko I.; Sinielnikov I.; Crabb S.J.; Syndikus I.; Huddart R.; Sundar S.; Chowdhury S.; Sarwar N.; Flaig T.W.; Pan C.X.; Schwarz J.K.; Cultrera J.L.; Acs P.I.; Hainsworth J.D.; Herms B.T.; Lawler W.E.; Lowe T.E.
臺大學術典藏 2022-09-15T01:09:01Z Docetaxel with or without Ramucirumab after Platinum-Based Chemotherapy and Checkpoint Inhibitors in Advanced Urothelial Carcinoma: A Pre-Specified Subgroup Analysis from the Phase 3 RANGE Trial Drakaki A.; Kirby C.J.; Van Der Heijden M.S.; Petrylak D.P.; Powles T.; Chi K.N.; Fl?chon A.; Necchi A.; G?czi L.; Lee J.-L.; Gakis G.; Bracarda S.; Chowdhury S.; Chia-Chi Lin; Keizman D.; Vaishampayan U.N.; Zimmermann A.H.; Bell-Mcguinn K.; Castellano D.
臺大學術典藏 2020-05-25T07:35:24Z An open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer Stadler W.M; Vaughn D.J; Sonpavde G; Vogelzang N.J; Tagawa S.T; Petrylak D.P; Rosen P; Chia-Chi Lin; Mahoney J; Modi S; Lee P; Ernstoff M.S; Su W.-C; Spira A; Pilz K; Vinisko R; Schloss C; Fritsch H; Zhao C; Carducci M.A.
臺大學術典藏 2020-05-25T07:35:14Z Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial Aarts M.J.B; Erdkamp F.L.G; Blaisse R.J.B; Flores C.L.U; Cort?s L.V; Lee Y.-G; Kim Y.J; Rha S.Y; Ferrario C; Sengeloev L; Jensen N.V; Thibault C; Laguerre B; Joly F; Flechon A; Culine S; Becht C; Niegisch G; St?ckle M; Grimm M.-O; Gakis G; Schultze-Seemann W; Kalofonos H; Mavroudis D; Papandreou C; Karavasilis V; R?v?sz J; Geczi L; Rosenbaum E; Leibowitz-Amit R; Kejzman D; Sarid D; Scagliotti G.V; Bracarda S; Massari F; Osawa T; Miyajima N; Shinohara N; Fukuta F; Ohyama C; Obara W; Yamashita S; Tomita Y; Kawai K; Fukasawa S; Oyama M; Yonese J; Nagata M; Uemura M; Nishimura K; Kawakita M; Tsunemori H; Hashine K; Inokuchi J; Yokomizo A; Nagamori S; Lee H.J; Park S.H; Alekseev B; Necchi A; G?czi L; Ou Y.-C; Coskun H.S; Su W.-P; Hegemann M; Percent I.J; Lee J.-L; Tucci M; Semenov A; Laestadius F; Peer A; Tortora G; Safina S; del Muro X.G; Rodriguez-Vida A; Cicin I; Harputluoglu H; Widau R.C; Liepa A.M; Walgren R.A; Hamid O; Zimmermann A.H; Bell-McGuinn K.M; Powles T; Wong S.-L.S; Tan T.H; Hovey E.J; Clay T.D; Ng S.S.W; Rutten A; Machiels J.-P; Dumez H; Cheng S.Y.-S; Petrylak D.P; de Wit R; Chi K.N; Drakaki A; Sternberg C.N; Nishiyama H; Castellano D; Hussain S; Fl?chon A; Bamias A; Yu E.Y; van der Heijden M.S; Matsubara N; Vaishampayan U.; Aragon-Ching J; Tagawa S; Lawler W; Lowe T; Herms B; Hainsworth J; Cultrera J; Schwarz J; Flaig T; Pan C.X; Wojcik-Tomaszewska J; Tomczak P; Sikora-Kupis B; Schenker M; Herzal A.A; Udrea A.A; Karlov P; Fomkin R; Pulido E.G; Mignorance J.I.D; Gauna D.C; Rodr?guez-Vida A; Su Y.-L; Lin C.-L; Chia-Chi Lin; Yeh S.-P; ?i?in I; Erman M; Urun Y; Golovko Y; Bondarenko I; Sinielnikov I; Crabb S; Syndikus I; Huddart R; Sundar S; Chowdhury S; Sarwar N
臺大學術典藏 2020-05-25T07:35:03Z Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial Petrylak D.P; de Wit R; Chi K.N; Drakaki A; Sternberg C.N; Nishiyama H; Castellano D; Hussain S.A; Fl?chon A; Bamias A; Yu E.Y; van der Heijden M.S; Matsubara N; Alekseev B; Necchi A; G?czi L; Ou Y.-C; Coskun H.S; Su W.-P; Bedke J; Gakis G; Percent I.J; Lee J.-L; Tucci M; Semenov A; Laestadius F; Peer A; Tortora G; Safina S; Garcia del Muro X; Rodriguez-Vida A; Cicin I; Harputluoglu H; Tagawa S.T; Vaishampayan U; Aragon-Ching J.B; Hamid O; Liepa A.M; Wijayawardana S; Russo F; Walgren R.A; Zimmermann A.H; Hozak R.R; Bell-McGuinn K.M; Powles T; Wong S.-L.S; Tan T.H; Hovey E.J; Clay T.D; Wan Ng S.S; Rutten A; Machiels J.-P; Dumez H; Cheng S.Y.-S; Ferrario C; Sengeloev L; Jensen N.V; Thibault C; Laguerre B; Joly F; Culine S; Becht C; Niegisch G; St?ckle M; Grimm M.-O; Schwentner C.A; Schultze-Seemann W; Kalofonos H; Mavroudis D; Papandreou C; Karavasilis V; R?v?sz J; Rosenbaum E; Leibowitz-Amit R; Kejzman D; Sarid D; Scagliotti G.V; Bracarda S; Massari F; Osawa T; Miyajima N; Shinohara N; Fukuta F; Ohyama C; Obara W; Yamashita S; Tomita Y; Kawai K; Fukasawa S; Oyama M; Yonese J; Nagata M; Uemura M; Nishimura K; Kawakita M; Tsunemori H; Hashine K; Inokuchi J; Yokomizo A; Nagamori S; Lee H.J; Park S.H; Rha S.Y; Kim Y.J; Lee Y.-G; Vazquez Cort?s L; Lorena Urzua Flores C; Blaisse R.J.B; Erdkamp F.L.G; Aarts M.J.B; Wojcik-Tomaszewska J; Tomczak P; Sikora-Kupis B; Schenker M; Herzal A.A; Udrea A.A; Karlov P; Fomkin R; Gajate Borau P; Grande E; Delgado Mignorance J.I; Su Y.-L; Li J.-R; Lin C.-L; Chia-Chi Lin; Yeh S.-P; Erman M; Urun Y; Golovko Y; Bondarenko I; Sinielnikov I; Crabb S.J; Syndikus I; Huddart R; Sundar S; Chowdhury S; Sarwar N; Flaig T.W; Pan C.X; Schwarz J.K; Cultrera J.L; Acs P.I; Hainsworth J.D; Herms B.T; Lawler W.E; Lowe T.E.
臺大學術典藏 2020 Docetaxel with or without Ramucirumab after Platinum-Based Chemotherapy and Checkpoint Inhibitors in Advanced Urothelial Carcinoma: A Pre-Specified Subgroup Analysis from the Phase 3 RANGE Trial Drakaki A; Kirby C.J; Van Der Heijden M.S; Petrylak D.P; Powles T; Chi K.N; Fl?chon A; Necchi A; G?czi L; Lee J.-L; Gakis G; Bracarda S; Chowdhury S; Chia-Chi Lin; Keizman D; Vaishampayan U.N; Zimmermann A.H; Bell-Mcguinn K; Castellano D.
國立成功大學 2020 Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial Petrylak, D.P.;de, Wit R.;Chi, K.N.;Drakaki, A.;Sternberg, C.N.;Nishiyama, H.;Castellano, D.;Hussain, S.A.;Fl�chon, A.;Bamias, A.;Yu, E.Y.;van, der Heijden M.S.;Matsubara, N.;Alekseev, B.;Necchi, A.;G�czi, L.;Ou, Y.-C.;Coskun, H.S.;Su, W.-P.;Bedke, J.;Gakis, Gakis G.;Percent, I.J.;Lee, J.-L.;Tucci, M.;Semenov, A.;Laestadius, F.;Peer, A.;Tortora, G.;Safina, Safina S.;Garcia, del Muro X.;Rodriguez-Vida, A.;Cicin, I.;Harputluoglu, Harputluoglu H.;Tagawa, S.T.;Vaishampayan, U.;Aragon-Ching, J.B.;Hamid, O.;Liepa, A.M.;Wijayawardana, S.;Russo, F.;Walgren, R.A.;Zimmermann, A.H.;Hozak, R.R.;Bell-McGuinn, K.M.;Powles, T.;Wong, S.-L.S.;Tan, Tan T.H.;Hovey, E.J.;Clay, T.D.;Wan, Ng S.S.;Rutten, A.;Machiels, J.-P.;Dumez, H.;Cheng, S.Y.-S.;Ferrario, C.;Sengeloev, L.;Jensen, N.V.;Thibault, C.;Laguerre, B.;Joly, F.;Culine, S.;Becht, C.;Niegisch, G.;St�ckle, M.;Grimm, M.-O.;Schwentner, C.A.;Schultze-Seemann, W.;Kalofonos, H.;Mavroudis, D.;Papandreou, C.;Karavasilis, V.;R�v�sz, J.;Rosenbaum, E.;Leibowitz-Amit, R.;Kejzman, D.;Sarid, D.;Scagliotti, G.V.;Bracarda, S.;Massari, F.;Osawa, T.;Miyajima, N.;Shinohara, N.;Fukuta, Fukuta F.;Ohyama, C.;Obara, W.;Yamashita, S.;Tomita, Y.;Kawai, Kawai K.;Fukasawa, S.;Oyama, M.;Yonese, J.;Nagata, M.;Uemura, M.;Nishimura, K.;Kawakita, M.;Tsunemori, H.;Hashine, K.;Inokuchi, J.;Yokomizo, A.;Nagamori, S.;Lee, H.J.;Park, S.H.;Rha, S.Y.;Kim, Y.J.;Lee, Y.-G.;Vazquez, Cort�s L.;Lorena, Urzua Flores C.;Blaisse, R.J.B.;Erdkamp, F.L.G.;Aarts, M.J.B.;Wojcik-Tomaszewska, J.;Tomczak, P.;Sikora-Kupis, B.;Schenker, M.;Herzal, A.A.;Udrea, A.A.;Karlov, P.;Fomkin, R.;Gajate, Borau P.;Grande, E.;Delgado, Mignorance J.I.;Su, Y.-L.;Li, J.-R.;Lin, C.-L.;Lin, C.-C.;Yeh, S.-P.;Erman, M.;Urun, Y.;Golovko, Y.;Bondarenko, I.;Sinielnikov, I.;Crabb, S.J.;Syndikus, I.;Huddart, R.;Sundar, Sundar S.;Chowdhury, S.;Sarwar, N.;Flaig, T.W.;Pan, C.X.;Schwarz, J.K.;Cultrera, J.L.;Acs, P.I.;Hainsworth, J.D.;Herms, B.T.;Lawler, W.E.;Lowe, T.E.

顯示項目 1-7 / 7 (共1頁)
1 
每頁顯示[10|25|50]項目